City

Porto (1)

Sherbrooke (1)

Condition

Cerebral Perfusion Pressure (3)

Cerebral Blood Flow (1)

Critically Ill (1)

Intracerebral Hemorrhage (1)

Intracranial Pressure (1)

Magnetic Resonance Imaging (MRI), Functional (1)

Prognostic (1)

Shock (1)

Vasopressor Agents (1)

Overall Status

Completed (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

Centre de recherche du Centre hospitalier universitaire de Sherbrooke (1)

Universidade do Porto (1)

Yu Liyun (1)

Collaborator

Intervention

higher doses of vasopressor therapy for a map of 75 mmhg (1)

lower doses of vasopressor therapy for a map of 65 mmhg (1)

measure toi and bp (1)

multimodal neuromonitoring (1)

propofol for light sedation (1)

Study Documents

Intervention Type

device (1)

diagnostic test (1)

drug (1)

Funder Type

Other (3)

Study Type

Observational (2)

Interventional (1)

cerebral perfusion pressure

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Early Multimodal Neuromonitoring Foi Spontaneous Intracerebral

Recruiting

Intracerebral Hemorrhage
+4 more

Multimodal Neuromonitoring

Porto, Portugal

Centro Hospitalar Universitário de São João

Aug 11, 2022

Cerebral Perfusion Pressure, Vasopressor Agents, Shock Trial in Sherbrooke (Higher doses of vasopressor therapy for a MAP of 75

Completed

Cerebral Perfusion Pressure
+3 more

Higher doses of vasopressor therapy for a MAP of 75 mmHg
+2 more

Sherbrooke, Quebec, Canada

Université de Sherbrooke

Mar 28, 2017

Cerebral Autoregulation With Near-infrared Spectroscopy

Unknown status

Cerebral Blood Flow
Cerebral Perfusion Pressure

measure TOI and BP

(no location specified)

Nov 15, 2016